comparemela.com

Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday. Separately, HC Wainwright cut their price objective on Taro Pharmaceutical Industries from $54.00 to $35.00 and set a “buy” rating on the […]

Related Keywords

Israel ,Canada , ,Taro Pharmaceutical Industries Trading Down ,News Ratings For Taro Pharmaceutical Industries Daily ,Alphacentric Advisors ,Taro Pharmaceutical Industries Ltd ,Taro Pharmaceutical Industries ,Murchinson Ltd ,Yd More Investments Ltd ,Get Rating ,Pharmaceutical Industries Trading Down ,Pharmaceutical Industries ,Centric Advisors ,Investments Ltd ,Taro Pharmaceutical Industries Daily ,Nyse Taro ,Taro ,Medical ,Upgrade ,Stocknews Com ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.